Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.
about
Targeting of interleukin-17 in the treatment of psoriasisManagement of moderate to severe psoriasis in patients with metabolic comorbiditiesCo-morbidity in psoriasis: mechanisms and implications for treatment.Recommendations for detection of individual risk for comorbidities in patients with psoriasis.Comorbidities and cardiovascular risk factors in patients with psoriasis.Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion.Metabolic syndrome and its components in patients with psoriasis.Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisPrevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis.Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.Cardiovascular comorbiditiy in psoriasisPsoriatic disease and tuberculosis nowadays.Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression.Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.Primary care-based screening for cardiovascular risk factors in patients with psoriasis.Predictors of biologic treatment of psoriasis: a non-interventional studyPrevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional studyPsoriasis and non-alcoholic fatty liver disease.What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010.Psoriasis: rationale for targeting interleukin-17.Cardiovascular aspects of psoriasis: an updated review.Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper.Co-morbidities in psoriasis: a hospital-based case-control study.Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.Complement C3 as a marker of cardiometabolic risk in psoriasis.Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring.High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital StudyObstacles and solutions to screening psoriasis patients for cardiovascular risk factors.Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES).Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study.Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).Psoriasis and Cardiovascular Risk: Correlation Between Psoriasis and Cardiovascular Functional Indices.
P2860
Q27026324-1037A433-7813-4C0C-B911-659EA6FD87A0Q28087039-1FB47AB5-F6AF-4599-BF86-2FC3CF76589DQ30248952-6CF53D04-B259-4141-A8DA-0FFF1D79E816Q30317889-C9E64F07-EE0B-47E8-8174-F7BE4F9486D1Q34140480-C5FCAC9D-E02E-4F76-A538-001C07389684Q34253312-045A9063-0B54-4B35-953F-E5473CFE3693Q34356844-65FB8A86-5585-4389-AEB3-0BC81DB19D8EQ34409690-10A379EE-AA42-4E6E-BAC8-8E57674CD402Q34638027-97BA0B78-09D5-4FF0-9D10-826C398D80D4Q34643790-51A04264-5850-49A2-A7FF-AF31437917C5Q34785993-4DC1793A-BEA7-4D49-AE9C-D35BF7A7AE53Q34812877-2F857E3D-C3A8-4C05-B897-FB9996EC8BFBQ35096973-170BFFA6-86EA-4444-81FF-EEE9BE2DE3B0Q35444953-665DD725-23F0-4F6D-8CF5-8778BC5667F9Q35564655-4DDEFB7A-6994-4ED0-ABDF-38DB7E151122Q35974892-4D1E668F-2485-4062-8F7D-04396E20DB60Q36016012-CAC88758-9206-4FDD-A8B9-64A07CEFE7D2Q36824796-0A26DE7B-2D1F-4AC4-8482-8E8C11EEF279Q37258726-6259CD1D-4480-4EB2-9848-3F857F907D7BQ37420435-C9A42B46-882B-4BDE-9BBE-AC0FABAE51A5Q37600690-2E547BC0-1B71-43D1-945C-6E770F10451BQ37644609-DA3C88E0-D7C7-43F9-A2EC-976576C0AF1FQ37788777-56D9E273-4314-49C0-9057-566A07F48FF8Q37896160-A2456AE9-6D1D-4299-B971-96B7FE72E804Q38020227-BCD2B3E6-DA8E-4C18-BEF6-E9BDC57EB58BQ38076496-20B3B99D-9F15-4DCF-9E90-875F5D4FF5AFQ38098647-A25764FA-7231-4EDD-8C5D-A3CA6A24469DQ38189108-29C1D892-CC37-4F5A-AA14-26891830A3F0Q38429390-ADC2AE6B-A954-4AA7-B695-2457C7761EDEQ38712213-1069C388-4BF3-4AFA-8DA0-CC8ECCB460E7Q38749538-DDCFAF69-D3AD-4A51-A708-F4D18EBFB22DQ39188717-97D6CF10-FC18-4EFE-86D5-E01CF8426BE9Q40419030-F6AFE56D-FDAB-41DE-93F9-1B5EB6A3AA93Q40988865-06EE7FCD-FAED-4E1D-9770-66A78F6361A4Q41515491-3C7B69A1-9A1D-4A84-9B25-3452D672D4C9Q45741250-41E3D1CD-090C-4C95-9F10-CB17E4D14769Q46386834-781FA40A-A0E4-4DFB-BF22-267CF810D4BAQ47319007-E1703EAA-9BE8-43D3-B01C-824B5D384D4FQ48239956-57B99421-CD03-46F9-A560-A951CDA84A6FQ48513946-28A79020-A13F-4A22-A5D6-39AAA2963942
P2860
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular risk factors in ...... ew of epidemiological studies.
@en
Cardiovascular risk factors in ...... ew of epidemiological studies.
@nl
type
label
Cardiovascular risk factors in ...... ew of epidemiological studies.
@en
Cardiovascular risk factors in ...... ew of epidemiological studies.
@nl
prefLabel
Cardiovascular risk factors in ...... ew of epidemiological studies.
@en
Cardiovascular risk factors in ...... ew of epidemiological studies.
@nl
P2093
P921
P1476
Cardiovascular risk factors in ...... iew of epidemiological studies
@en
P2093
J-P Ortonne
M Le Maitre
M-A Richard-Lallemand
P-A Gourraud
P356
10.1111/J.1468-3083.2009.03564.X
P478
24 Suppl 2
P577
2010-04-01T00:00:00Z